Ondansetron HCl 4 mg Oral Tablet
RxNorm 198052
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 198052 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: ondansetron HCl 4 mg Oral Tablet.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCDPrescribable
Semantic Clinical Drug (SCD):
Ondansetron 4 mg Oral Tablet
(Atom ID: 12324534)
PTPrescribable
Designated preferred name (PT):
Ondansetron (as ondansetron hydrochloride) 4 mg oral tablet
(Atom ID: 10302575)
SYPrescribable
Synonym (SY):
Ondansetron 4 mg (as ondansetron HCl dihydrate 5 mg) Oral Tablet
(Atom ID: 8727884)
PSNPrescribable
Prescribable Name (PSN):
Ondansetron HCl 4 mg Oral Tablet
(Atom ID: 6810710)
FNPrescribable
Full form of descriptor (FN):
Product containing precisely ondansetron (as ondansetron hydrochloride) 4 mg/1 each conventional release oral tablet (clinical drug)
(Atom ID: 10315643)
Patient Education
Ondansetron
Ondansetron is used to prevent nausea and vomiting caused by cancer chemotherapy, radiation therapy, and surgery. Ondansetron is in a class of medications called serotonin 5-HT3 receptor antagonists. It works by blocking the action of serotonin, a natural substance that may cause nausea and vomiting.
[Learn More]
* Please review the disclaimer below.